Accessing the inaccessible: research bridging academia and industry – an interview with Tatiana Rogova
Member Exclusive Interview
Expert interviews, Drug discovery approaches, Drug regulation and industry, Preclinical studies and Phase I, Technologies and methodologies, Neurological & Psychiatric , Respiratory , Cardiovascular , Digestive , Infectious , Cancer , Early Career Room
Advancing the discovery of CNS active drugs: an interview with Li Yu and Holger Fischer
Free-energy analysis in drug discovery: an interview with Stefano Leoni
Increasing predictability in drug discovery using nanoinformatics: an interview with Yosi Shamay
A peek behind the paper: compound optimization monitor (COMO) for computational evaluation of lead optimization
From the journal, Expert interviews, A peek behind the paper , Computational chemistry and informatics, Preclinical studies and Phase I, Technologies and methodologies
Dual functional delivery strategy for cancer immunotherapy: an interview with Zhuoya Wan
NMR structure opens doors for thrombosis therapeutic strategy: an interview with Ana Paula Valente
Ask the experts: what do the next 5—10 years look like for artificial intelligence?
Ask the experts: is there too much hype surrounding the promise of artificial intelligence?
Ask the experts: how can artificial intelligence address some of the problems faced by drug discovery?